1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Trabedersen: new trials by email Literature Review of Trabedersen trials Research Report on Trabedersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 AP 12009 - Pancreatic Neoplasms, Melanoma | Phase 1 | Completed | Isarna Therapeutics GmbH | 62 | 2005-01-01 | 2019-02-15 |
Colorectal Neoplasms (1) · Melanoma (1) · Pancreatic Neoplasms (1)
Germany (1)